Pulse Biosciences (PLSE) Share-based Compensation (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Share-based Compensation of -$16.5 million for Q4 2025, down 342.71% year-over-year from $6.8 million in Q4 2024, and down 393.52% quarter-over-quarter from $5.6 million in Q3 2025.
Pulse Biosciences (PLSE) Share-based Compensation (2015 - 2026) Analysis & Trends
Pulse Biosciences' Share-based Compensation history runs 11 years deep, the most recent figure standing at -$16.5 million for Q4 2025.
- In Q4 2025, Share-based Compensation fell 342.71% year-over-year to -$16.5 million; the TTM figure through Sep 2025 stood at $23.3 million (up 139.82% YoY), while the FY2025 annual figure was $27.6 million, up 52.49% from the prior year.
- Share-based Compensation for Q4 2025 stood at -$16.5 million, down from $5.6 million in the prior quarter.
- The five-year high for Share-based Compensation was $6.8 million in Q4 2024, with the low at -$65.2 million in Q4 2023.
- The 5-year median for Share-based Compensation is $1.8 million (2023), against an average of -$1.9 million.
- Peak annual rise in Share-based Compensation reached 222.97% in 2025, while the deepest fall reached 342.71% in 2025.
- Pulse Biosciences' Share-based Compensation stood at -$397000.0 in 2021, then surged by 282.12% to $723000.0 in 2022, then slumped by 9124.76% to -$65.2 million in 2023, then soared by 110.41% to $6.8 million in 2024, then tumbled by 342.71% to -$16.5 million in 2025.
- Business Quant data shows PLSE's Share-based Compensation at -$16.5 million in Q4 2025, $5.6 million in Q3 2025, and $5.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Pulse Biosciences | 3.33 Bn | 3.33 Bn | 161,000.00 | 73.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.88 Mn |
| Jun 30, 2026 | 73.88 Mn |
| Dec 31, 2025 | -16.49 Mn |
| Dec 31, 2025 | -16.49 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 2.98 Mn |
| Sep 30, 2024 | 2.98 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | -65.25 Mn |
| Dec 31, 2023 | -65.25 Mn |